Literature DB >> 10867013

Activated Raf inhibits myogenesis through a mechanism independent of activator protein 1-mediated myoblast transformation.

C M Dorman1, S E Johnson.   

Abstract

Skeletal myogenesis is acutely affected by growth factors and subsequent activation of their respective intracellular signaling cascades. Components of the mitogenic Ras/Raf/mitogen-activated protein kinase (MAPK) signaling module are potent inhibitors of myoblast differentiation. However, the means by which these kinases prevent myocyte formation and activation of the muscle gene program is unknown. Activator protein 1 (AP-1) is a transcriptional regulator the actions of which are up-regulated by signaling events, including elevated MAPK. Because activated Raf inhibits avian myogenesis in a MAPK-dependent fashion, we investigated the role of AP-1 as a mediator of the Raf-imposed block to myogenesis. Avian myoblasts overexpressing activated Raf contain elevated levels of AP-1 DNA binding and transcriptional activity. Introduction of an AP-1 dominant inhibitory protein (AFOS) into Raf-expressing myoblasts prevented acquisition of a transformed morphology. Interestingly, these cells remained differentiation-defective. Myogenic cells cotransduced with RCAS(A)-Raf BXB and RCAS(B)-AFOS remained mononuclear and myosin-negative and did not activate significantly muscle-specific reporter genes. These results argue that Raf inhibits muscle differentiation independent of AP-1-mediated cell transformation. Our results provide evidence for AP-1 as a critical component of the transforming capacity of activated Raf and evidence that AP-1 is not involved in the myogenic inhibitory effects of the kinase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10867013     DOI: 10.1074/jbc.M004802200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  2 in total

1.  MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma.

Authors:  Marielle E Yohe; Berkley E Gryder; Jack F Shern; Young K Song; Hsien-Chao Chou; Sivasish Sindiri; Arnulfo Mendoza; Rajesh Patidar; Xiaohu Zhang; Rajarashi Guha; Donna Butcher; Kristine A Isanogle; Christina M Robinson; Xiaoling Luo; Jin-Qiu Chen; Ashley Walton; Parirokh Awasthi; Elijah F Edmondson; Simone Difilippantonio; Jun S Wei; Keji Zhao; Marc Ferrer; Craig J Thomas; Javed Khan
Journal:  Sci Transl Med       Date:  2018-07-04       Impact factor: 17.956

2.  RIP2, a checkpoint in myogenic differentiation.

Authors:  Barbara Munz; Eberhard Hildt; Matthew L Springer; Helen M Blau
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.